HSA Product

GLIOTENZIDE 20 TABLET

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

GLIOTENZIDE 20 TABLET

Dosage Form

TABLET

Regulatory Information

Approval Number

SIN12641P

Approval Date

January 14, 2005

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 4, 2025

ATC Business ID

XC09BA02

Company Information

ManufacturerLABORATORIOS BAGO SA

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Active Ingredients

ENALAPRIL MALEATE USP

Strength: 20 mg

HYDROCHLOROTHIAZIDE USP

Strength: 12.5 mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy